Soliqua

Soliqua Caution For Usage

insulin glargine + lixisenatide

Manufacturer:

sanofi-aventis

Distributor:

DKSH
Full Prescribing Info
Caution For Usage
Incompatibilities: This medicinal product must not be mixed with other medicinal products.
Special precautions for disposal and other handling: Before first use, the pen must be taken out of the refrigerator and stored below 25°C for 1 to 2 hours.
The cartridge should be inspected before use. It must only be used if the solution is clear, colourless, with no solid particles visible, and if it is of water-like consistency.
Soliqua must not be mixed with any other insulin or diluted. Mixing or diluting can change its time/action profile and mixing can cause precipitation.
A new needle must always be attached before each use. Needles must not be re-used. The patient should discard the needle after each injection.
In the event of blocked needles patients must follow the instructions described in the "Instructions for Use" accompanying the package leaflet.
Empty pens must never be reused and must be properly discarded.
To prevent the possible transmission of disease, each pen must be used by one patient only.
The label must always be checked before each injection to avoid medication errors between Soliqua and other injectable anti-diabetic medicinal products, including the 2 different pens of Soliqua (see Precautions). Before using Soliqua, the instructions for use included in the package leaflet must be read carefully.
Any unused medicinal product or waste material should be disposed of in accordance with local requirements.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in